nab001
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01208168)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2INHIBITOR
SARS-CoV-2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nab001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01208129 | Phase 3 | Sep 1, 2010 | Dr. Reddy's Laboratories |
| NCT01208168 | Phase 3 | Sep 1, 2010 | Dr. Reddy's Laboratories |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dr. Reddy's Laboratories | For profit | 2 | 2 | 1 | 2010 |
1 organizations
Page 1 / 1